Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 6, Pages 796
Publisher
MDPI AG
Online
2019-06-06
DOI
10.3390/jcm8060796
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction
- (2019) Sébastien Miranda et al. PLoS One
- A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus
- (2019) Ming-Ming Gu et al. IMMUNOLOGICAL INVESTIGATIONS
- Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus
- (2019) Hironari Hanaoka et al. INTERNAL MEDICINE
- Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis
- (2018) Dag Leonard et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
- (2018) Maria Wigren et al. ATHEROSCLEROSIS
- Hydroxychloroquine: An old drug with new relevance
- (2018) E. A. SHIPPEY et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study
- (2018) Hong-Wei Tam et al. International Journal of Rheumatic Diseases
- Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
- (2018) Alberto Floris et al. MEDIATORS OF INFLAMMATION
- Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis
- (2018) Soo-Kyung Cho et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis
- (2018) Dan Liu et al. Drug Design Development and Therapy
- Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome
- (2018) Geoffrey Urbanski et al. PLoS One
- Association between ischemic heart disease and systemic lupus erythematosus—a large case-control study
- (2017) Abdulla Watad et al. IMMUNOLOGIC RESEARCH
- The antiphospholipid syndrome in patients with systemic lupus erythematosus
- (2017) Guillermo J. Pons-Estel et al. JOURNAL OF AUTOIMMUNITY
- Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
- (2017) Serena Fasano et al. JOURNAL OF RHEUMATOLOGY
- Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine
- (2017) Ji-Won Kim et al. JOURNAL OF RHEUMATOLOGY
- The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies
- (2017) Karen Schreiber et al. RHEUMATOLOGY
- Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase
- (2016) Nadine Müller-Calleja et al. ANNALS OF THE RHEUMATIC DISEASES
- Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis
- (2016) Guo-Cui Wu et al. AUTOIMMUNITY REVIEWS
- Echocardiographic findings in asymptomatic systemic lupus erythematosus patients
- (2016) Abdel GaffarA. Mohammed et al. CLINICAL RHEUMATOLOGY
- Hydroxychloroquine in systemic lupus erythematosus (SLE)
- (2016) C. Ponticelli et al. Expert Opinion On Drug Safety
- Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus
- (2015) Timothy A. Gottschalk et al. Frontiers in Immunology
- Mortality and Cardiovascular Burden of Systemic Lupus Erythematosus in a US Population-based Cohort
- (2014) C. M. Bartels et al. JOURNAL OF RHEUMATOLOGY
- Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus
- (2014) E. Ammirati et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Associations of Hydroxychloroquine Use With Lipid Profiles in Rheumatoid Arthritis: Pharmacologic Implications
- (2014) Gail Kerr et al. ARTHRITIS CARE & RESEARCH
- Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
- (2012) L. S. Magder et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Features associated with cardiac abnormalities in systemic lupus erythematosus
- (2011) J Bourré-Tessier et al. LUPUS
- Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients
- (2011) S Sazliyana et al. LUPUS
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients
- (2010) Stephanie J. Morris et al. ARTHRITIS CARE & RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search